V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290005006 | 290006588 | 1.68 | 119 | Curative (C) | 2015-08-10 | 2015-08-10 | Folfirinox | 02 | null | 290022186 | INTERFERON |
| 290005007 | 290003663 | 1.74 | 46.4 | Curative (C) | 2016-08-25 | 2016-09-01 | CISPLATIN + FLUOROURACIL + MITOMYCIN | N | Y | 290022188 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005008 | 290003664 | 1.61 | 75.3 | Palliative (P) | 2016-05-18 | 2016-05-18 | Capecitabine | N | N | 290022191 | ECX |
| 290005009 | 290003665 | 1.65 | 59.1 | Neo-adjuvant (N) | 2018-02-19 | 2018-03-19 | CISPLATIN + FLUOROURACIL | 02 | Y | 290022192 | CAPECITABINE + CARBOPLATIN |
| 290005010 | 290006589 | 1.62 | 69.9 | Adjuvant (A) | 2015-03-26 | 2015-04-01 | Cisplatin + Fluorouracil + RT 5day | N | N | 290022193 | PEMBROLIZUMAB |
| 290005011 | 290003666 | 1.62 | 68 | Palliative (P) | 2013-03-08 | 2013-03-11 | Capecitabine | N | N | 290022195 | CAPE + CARBOPLATIN + CETUXIMAB |
| 290005012 | 290003666 | 1.66 | 0 | Adjuvant (A) | 2017-07-18 | 2017-08-06 | CAPECITABINE + RT | N | Y | 290022195 | FLUOROURACIL |
| 290005013 | 290003667 | 1.78 | 72.5 | Palliative (P) | 2015-12-29 | 2015-12-29 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022197 | ECF |
| 290005014 | 290003668 | 1.78 | 78 | Palliative (P) | 2016-09-23 | 2016-10-11 | Cisplatin + Fluorouracil + RT 5day | N | N | 290022198 | CAPECITABINE |
| 290005015 | 290003669 | 1.69 | 84.9 | Curative (C) | 2013-08-15 | 2013-08-20 | Cisplatin + Docetaxel +Fluorouracil | N | Y | 290022199 | CAPECITABINE |
| 290005016 | 290003670 | 1.6 | 67.3 | Disease modification (D) | null | 2016-09-13 | LANREOTIDE | N | N | 290022201 | CAPECITABINE + RT |
| 290005017 | 290006591 | 1.78 | 87.2 | Palliative (P) | 2014-03-02 | 2014-03-13 | GemCarbo Days 1+8 | N | N | 290022203 | GEMCITABINE |
| 290005018 | 290003671 | 0 | 77.8 | Palliative (P) | 2017-08-08 | 2017-08-17 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022204 | CARBOPLATIN + RT |
| 290005019 | 290003671 | 1.69 | null | Palliative (P) | 2016-10-01 | 2016-10-12 | Sunitinib 37.5mg continuous | 02 | N | 290022204 | CAPECITABINE + RT |
| 290005020 | 290003671 | null | 68.2 | Curative (C) | 2016-07-29 | 2016-08-25 | PLATO Trials | Y | Y | 290022204 | ECX |
| 290005021 | 290003672 | 1.6 | 75.3 | Neo-adjuvant (N) | 2017-08-21 | 2017-08-21 | Carboplatin + Etoposide IV 3 day | 2 | null | 290022208 | CAPECITABINE |
| 290005022 | 290003673 | 1.63 | 78 | Palliative (P) | 2016-09-05 | 2016-09-07 | GemCarbo Days 1+8 | N | N | 290022211 | ECX |
| 290005023 | 290003674 | 1.57 | 102 | Disease modification (D) | 2017-09-07 | 2017-09-26 | CETUXIMAB + RT | N | N | 290022214 | GEMCITABINE |
| 290005024 | 290003674 | 1.64 | 0 | Palliative (P) | 2017-04-05 | 2017-04-08 | Capecitabine | 02 | N | 290022214 | EOX |
| 290005025 | 290003675 | 1.67 | 88.4 | null | 2016-03-20 | 2016-03-28 | Carboplatin + Etoposide IV 3 day | N | N | 290022217 | CAPECITABINE + RT |
| 290005026 | 290003675 | 1.71 | 93.7 | Palliative (P) | 2017-08-19 | 2017-09-03 | Irinotecan + Modified De Gramont | 02 | N | 290022217 | PLATO TRIAL |
| 290005027 | 290003675 | null | 43.7 | Palliative (P) | 2015-02-16 | 2015-02-16 | Capecitabine | 02 | N | 290022217 | COMPARE TRIAL |
| 290005028 | 290003676 | 1.86 | 73.8 | Palliative (P) | 2018-08-11 | 2018-08-22 | CETUXIMAB | 02 | N | 290022222 | CAPECITABINE + RT |
| 290005029 | 290003677 | 1.72 | 62 | Palliative (P) | 2018-07-07 | 2018-07-26 | Capecitabine 5days + RT | N | N | 290022223 | CAPECITABINE + RT |
| 290005030 | 290003678 | 1.7 | 78.6 | Palliative (P) | 2015-03-18 | 2015-04-07 | CISPLATIN + FLUOROURACIL | 02 | N | 290022227 | IRINOTECAN + MDG |
| 290005031 | 290006595 | 1.46 | 83.3 | null | 2015-09-06 | 2015-09-06 | EOX | 02 | null | 290022229 | CISPLATIN + FLUOROURACIL |
| 290005032 | 290003679 | 1.84 | 63.3 | Palliative (P) | 2015-10-14 | 2015-10-16 | IVA | 2 | N | 290022237 | CAPECITABINE |
| 290005033 | 290006596 | 1.53 | 64.9 | Neo-adjuvant (N) | null | 2015-06-09 | CARBOPLATIN + ETOPOSIDE | N | N | 290022241 | FLUOROURACIL |
| 290005034 | 290003680 | 1.74 | 65.9 | Palliative (P) | 2015-08-13 | 2015-09-09 | Capecitabine | N | N | 290022243 | DACARBAZINE |
| 290005035 | 290003680 | 1.72 | 82.4 | null | null | 2015-02-15 | Gemcitabine weekly | null | null | 290022243 | CARBO + FLUOROURACIL |
| 290005036 | 290003681 | 1.78 | 73.8 | Neo-adjuvant (N) | 2015-03-10 | 2015-03-16 | GemCarbo Days 1+8 | N | Y | 290022245 | CAPECITABINE + RT |
| 290005037 | 290003682 | 1.89 | 85 | Disease modification (D) | 2013-08-29 | 2013-09-10 | FLUOROURACIL | N | N | 290022246 | CAPECITABINE |
| 290005038 | 290003683 | null | null | Palliative (P) | null | 2014-10-14 | Cisplatin +Fluorouracil (2 wk) | N | N | 290022247 | CISPLATIN + FLUOROURACIL + RT |
| 290005039 | 290003684 | 1.74 | 95.7 | Palliative (P) | 2018-12-22 | 2019-01-11 | ECX | N | N | 290022248 | DOXORUBICIN |
| 290005040 | 290003685 | 1.55 | 96.2 | Palliative (P) | 2014-10-08 | 2014-10-18 | null | N | N | 290022250 | CAPECITABINE + RT |
| 290005041 | 290003685 | 1.48 | 0 | Palliative (P) | 2018-05-09 | 2018-06-07 | PEMBROLIZUMAB | 02 | N | 290022250 | CAPECITABINE + GEMCITABINE |
| 290005042 | 290003685 | 0 | 82.3 | Palliative (P) | 2017-07-11 | 2017-07-11 | Irinotecan + Modified De Gramont | 02 | N | 290022250 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005043 | 290008199 | 1.75 | 61 | Palliative (P) | 2016-04-05 | 2016-04-25 | PEMBROLIZUMAB | N | N | 290022254 | ECX |
| 290005044 | 290008199 | 1.6 | 59.4 | Palliative (P) | null | 2016-02-12 | Cetuximab + Oxaliplatin + MdG Maint | N | N | 290022254 | CAPECITABINE |
| 290005045 | 290003686 | 1.6 | 70.9 | Neo-adjuvant (N) | 2013-01-12 | 2013-02-01 | Capecitabine + Cisplatin | N | N | 290022257 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290005046 | 290003687 | null | 49 | Adjuvant (A) | 2016-01-16 | 2016-01-29 | LANREOTIDE | 02 | N | 290022258 | CAPECITABINE + RT |
| 290005047 | 290006599 | 1.7 | 71.85 | Neo-adjuvant (N) | 2016-08-22 | 2016-10-18 | Cisplatin +Fluorouracil (3 wk) | N | N | 290022260 | CISPLATIN + FLUOROURACIL |
| 290005048 | 290006599 | null | 69.3 | Not known (9) | 2015-07-23 | 2015-07-26 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022260 | FLUOROURACIL |
| 290005049 | 290003688 | 1.77 | 65.6 | Palliative (P) | 2015-07-01 | 2015-07-11 | Capecitabine 35days + RT | 02 | N | 290022264 | CAPECITABINE + RT |
| 290005050 | 290003689 | 1.69 | 87.1 | Disease modification (D) | 2014-04-06 | 2014-04-07 | Docetaxel 75mg/m2 (21 day) | 02 | null | 290022268 | EVEROLIMUS |
| 290005051 | 290003690 | 1.7 | null | Palliative (P) | 2016-02-06 | 2016-03-01 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 290022269 | CAPECITABINE |
| 290005052 | 290003690 | 1.5 | 87.8 | Palliative (P) | 2014-09-25 | 2014-09-25 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 290022269 | CETUXIMAB + RT |
| 290005053 | 290003690 | 1.66 | 60.9 | Palliative (P) | 2015-05-13 | 2015-06-10 | CARBOPLATIN + FLUOROURACIL | 2 | N | 290022269 | CAPECITABINE + RT |
| 290005054 | 290003691 | 1.8 | 63.6 | Palliative (P) | 2016-05-20 | 2016-05-26 | PLATO Trials | 02 | null | 290022272 | CAPECITABINE |
| 290005055 | 290003691 | 1.7 | 98 | Palliative (P) | 2016-01-11 | 2016-01-25 | Capecitabine + Cisplatin | 02 | N | 290022272 | CISPLATIN + FLUOROURACIL + RT |